Product NDC: | 0095-0073 |
Proprietary Name: | HYLASE Wound |
Non Proprietary Name: | Sodium Hyaluronate |
Active Ingredient(s): | 2.5 g/100g & nbsp; Sodium Hyaluronate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0095-0073 |
Labeler Name: | ECR Pharmaceuticals Co., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120106 |
Package NDC: | 0095-0073-75 |
Package Description: | 1 TUBE in 1 CARTON (0095-0073-75) > 75 g in 1 TUBE |
NDC Code | 0095-0073-75 |
Proprietary Name | HYLASE Wound |
Package Description | 1 TUBE in 1 CARTON (0095-0073-75) > 75 g in 1 TUBE |
Product NDC | 0095-0073 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sodium Hyaluronate |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20120106 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | ECR Pharmaceuticals Co., Inc. |
Substance Name | HYALURONATE SODIUM |
Strength Number | 2.5 |
Strength Unit | g/100g |
Pharmaceutical Classes |